# approved_drugs
Track hit to lead campaigns of all approved small molecules


## List

### 2019

 - alpelisib (Piqray; Novartis)
 - erdafitinib (Balversa; Janssen)

### 2018

 - glasdegib (Daurismo; Pfizer)
 

![Alt text](image.png?raw=true )
